Furthermore, using an inducible expression system for AR-V7, we generated LNCaP cells that can express both AR-FL and AR-V7, which mimics the clinical state of the majority of PCa patients with resistance to enzalutamide or abiraterone52. Here, AR is linked to posterior cortical atrophy.